# US 2004/0266703 A1 · Method for extracting a macrolide from biomatter

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0266703 A1
- Document ID: US20040266703A1
- Status: Published application
- Kind: A1
- Application number: 10/844,764
- Filed: 2004-05-12
- Published: 2004-12-30
- Earliest claimed: 2002-02-13
- Assignees: TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság
- Inventors: Vilmos Keri; Janos Rako; Ferenc Rantal; Andrea Csorvasi
- Web page: https://patentgrep.com/patent/US20040266703A1

## CPC

- C07D 498/18: Bridged systems
- Y10S 435/898: Streptomyces hygroscopicus
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Provided is a method for obtaining a macrolide, especially tacrolimus, ascomycin, pimecrolimus, sirolimus, or everolimus, from biomatter.

## Claims

### Claim 1

A method for obtaining a macrolide selected from the group consisting of ascomycin, pimecrolimus, sirolimus, and everolimus comprising the step of extracting macrolide-containing biomatter with a hydrophobic extraction solvent to obtain a solution of the macrolide in the hydrophobic extraction solvent, wherein the pH of the macrolide-containing biomatter being extracted is between about 5.5 and about 13, wherein the macrolide-containing biomatter is ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomatter when pimecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-containing biomatter when everolimus is to be obtained.

### Claim 2 (depends on 1)

The method of claim 1 wherein the hydrophobic extraction solvent is selected from the group consisting of n-butanol, iso-butanol, C2-C6 linear and branched esters of acetic acid or formic acid, C3-C6 linear or branched aliphatic ketones, halogenated methanes, halogenated ethanes, and aromatic hydrocarbons that are liquid at 25° C. and that have a boiling point at atmospheric pressure less than about 150° C.

### Claim 3 (depends on 2)

The method of claim 2 wherein the hydrophobic extraction solvent is selected from the group consisting of n-butanol, iso-butanol, n-butyl acetate, iso-butyl acetate, t-butyl acetate, ethyl acetate, propyl acetate, ethyl formate, acetone, butyl methyl ketone, methyl iso-butyl ketone, dichloromethane, chloroform, tetrachloromethane, dichloroethane, and toluene.

### Claim 4 (depends on 3)

The method of claim 3 wherein the hydrophobic extraction solvent is ethyl acetate, iso-butyl acetate, or a mixture of these.

### Claim 5 (depends on 4)

The method of claim 4 wherein the hydrophobic extraction solvent is iso-butyl acetate.

### Claim 6 (depends on 1)

The method of claim 1 wherein the extraction is at a temperature between about 2° C. and about 70° C.

### Claim 7 (depends on 6)

The method of claim 6 wherein the extraction is at a temperature between about 15° C. and about 35° C.

### Claim 8 (depends on 1)

The method of claim 1 wherein the pH of the biomatter extracted is between about 7.5 and about 13.

### Claim 9 (depends on 1)

The method of claim 1 wherein the macrolide-containing biomatter is obtained from a microorganism selected from Streptomyces tsukubaensis, Streptomyces hygroscopicus, Streptomyces lividans, Streptomyces hygroscopicus hygroscopicus, and Streptomyces hygroscopicus ascomyceticus.

### Claim 10 (depends on 9)

The method of claim 9 wherein the macrolide-containing biomatter is whole fermentation broth.

### Claim 11 (depends on 10)

The method of claim 10 wherein the macrolide is ascomycin.

### Claim 12 (depends on 10)

The method of claim 10 wherein the macrolide is pimecrolimus.

### Claim 13 (depends on 10)

The method of claim 10 wherein the macrolide is sirolimus.

### Claim 14 (depends on 10)

The method of claim 10 wherein the macrolide is everolimus.

### Claim 15 (depends on 11, 12, 13)

The method as in claims 11, 12, 13, or 14 wherein the pH of the biomatter is between about 7.5 and about 13.

### Claim 16 (depends on 15)

The method of claim 15 wherein the hydrophobic extraction solvent is iso-butyl acetate.

### Claim 17 (depends on 1)

The method of claim 1 further comprising the steps of, after extraction;
separating the solution containing the macrolide from the extracted macrolide-containing biomatter,
concentrating the separated macrolide-containing solution,
loading the concentrated macrolide-containing solution onto a silica gel column and eluting with an eluent to obtain at least one macrolide-containing fraction that is a macrolide-containing solution,
crystallizing the macrolide from the macrolide-containing solution, and isolating the crystallized macrolide.

### Claim 18 (depends on 17)

The method of claim 17 wherein the crystallizing is effected by concentrating at least one macrolide-containing fraction that is a macrolide-containing solution and cooling the concentrated solution to a temperature of about 25° C. or less.

### Claim 19 (depends on 17)

The method of claim 17 wherein the crystallization is effected by combining the separated solution with a crystallization solvent.

### Claim 20 (depends on 19)

The method of claim 19 wherein the crystallization solvent is selected from the group consisting of acetonitrile, methanol, ethanol, i-propanol, acetone, diethyl ether, ethyl acetate, the hexanes, the heptanes, and water.

### Claim 21 (depends on 20)

The method of claim 20 wherein the crystallization solvent is selected from the group consisting of methanol, ethanol, i-propanol, and water.

### Claim 22 (depends on 19)

The method of claim 19 wherein the combination of separated solution and crystallization solvent is maintained at a temperature of about 25° C. or less for a holding period of between about 10 and about 60 hours.

### Claim 23

A method of obtaining a macrolide selected from the group consisting of ascomycin, pimecrolimus, sirolimus, and everolimus from macrolide-containing biomatter, wherein the macrolide-containing biomatter is ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomatter when pimecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-containing biomatter when everolimus is to be obtained, comprising the steps of:
a) extracting macrolide-containing biomatter that is whole fermentation broth obtained by fermentation of a microorganism selected from the group consisting of Streptomyces tsukubaensis, Streptomyces hygroscopicus, Streptomyces lividans, Streptomyces hygroscopicus hygroscopicus, and Streptomyces hygroscopicus ascomyceticus with a hydrophobic extraction solvent selected form the group consisting of n-butanol, iso-butanol, n-butyl acetate, iso-butyl acetate, t-butyl acetate, ethyl acetate, propyl acetate, ethyl formate, butyl methyl ketone, dichloromethane, chloroform, tetrachloromethane, dichloroethane and toluene to obtain a solution of macrolide in hydrophobic extraction solvent at a temperature between about 2° C. and about 70° C. and a pH between about 5.5 and about 13,
b) separating the macrolide-containing solution from the extracted macrolide-containing biomatter,
c) concentrating the macrolide-containing solution,
d) loading the concentrated macrolide-containing solution onto a silica gel chromatography column and eluting the column with an eluent to obtain at least one macrolide-containing fraction that is a macrolide-containing solution,
e) crystallizing the macrolide from at least one macrolide-containing fraction whereby a precipitate of crystallized macrolide is formed, and
f) separating crystallized macrolide.

### Claim 24 (depends on 23)

The method of claim 23 wherein the pH of the whole fermentation broth is between about 7.5 and about 13.

### Claim 25 (depends on 23)

The method of claim 23 wherein the hydrophobic extraction solvent is iso-butyl acetate.

### Claim 26 (depends on 23)

The method of claim 23 wherein the extraction is at a temperature between about 15° C. and about 30° C.

### Claim 27

The method of clam 23 wherein the crystallization is effected by concentrating the at least one macrolide-containing fraction and cooling the concentrated fraction to a temperature of about 25° C. or less.

### Claim 28 (depends on 23)

The method of claim 23 wherein the crystallization is effected by combining the at least one macrolide-containing fraction with a crystallization solvent selected from the group consisting of acetonitrile, methanol, ethanol, acetone, diethyl ether, ethyl acetate, the hexanes, the heptanes, and water.

### Claim 29

In a process for obtaining a macrolide selected from the group consisting of ascomycin, pimecrolimus, sirolimus, and everolimus from macrolide-containing biomatter, wherein the macrolide-containing biomatter is ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomatter when pimecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-containing biomatter when everolimus is to be obtained, the step of extracting macrolide-containing biomatter that is whole fermentation broth with a hydrophobic extraction solvent selected from the group consisting of n-butyl acetate, iso-butyl acetate, t-butyl acetate, ethyl acetate, propyl acetate, ethyl formate, butyl methyl ketone, dichloromethane, chloroform, tetrachloromethane, and toluene, wherein the pH of the macrolide-containing biomatter is between about 5.5 and about 13.

### Claim 30

A method of obtaining a macrolide selected from the group consisting of ascomycin, pimecrolimus, sirolimus, and everolimus from macrolide-containing biomatter, wherein the macrolide-containing biomatter is ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomatter when pimecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-containing biomatter when everolimus is to be obtained, comprising the steps of:
a) extracting a macrolide-containing biomatter that is whole fermentation broth obtained by fermentation of a microorganism selected from the group consisting of Streptomyces tsukubaensis, Streptomyces hygroscopicus, Streptomyces lividans, Streptomyces hygroscopicus hygroscopicus, and Streptomyces hygroscopicus ascomyceticus with iso-butyl acetate to obtain a solution of a macrolide in iso-butyl acetate at a temperature between about 2° C. and about 70° C.,
b) separating the macrolide-containing solution from the extracted macrolide-containing biomatter,
c) concentrating the macrolide-containing solution,
d) loading the concentrated macrolide-containing solution onto a silica gel chromatography column and eluting with an eluent to obtain at least one macrolide-containing fraction that is a macrolide-containing solution,
e) concentrating at least one macrolide-containing fraction,
f) crystallizing the macrolide from the concentrated fraction, whereby a precipitate of crystallized macrolide is formed, and
g) separating crystallized macrolide.

### Claim 31 (depends on 30)

The method of claim 30 wherein the pH of the macrolide-containing biomatter is about 7.5 to about 13.

### Claim 32 (depends on 30)

The method of claim 30 wherein the temperature of extraction is between about 15° C. and about 35° C.
